174 related articles for article (PubMed ID: 38634216)
21. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
Zorzi M; Battagello J; Selby K; Capodaglio G; Baracco S; Rizzato S; Chinellato E; Guzzinati S; Rugge M
Gut; 2022 Mar; 71(3):561-567. PubMed ID: 33789965
[TBL] [Abstract][Full Text] [Related]
22. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
[TBL] [Abstract][Full Text] [Related]
23. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
Ladabaum U; Shepard J; Mannalithara A
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2895-2904.e4. PubMed ID: 35580769
[TBL] [Abstract][Full Text] [Related]
24. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
25. Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy.
Waldmann E; Kammerlander AA; Gessl I; Penz D; Majcher B; Hinterberger A; Bretthauer M; Trauner MH; Ferlitsch M
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1890-1898. PubMed ID: 33878471
[TBL] [Abstract][Full Text] [Related]
26. Participation and yield of a population-based colorectal cancer screening programme in China.
Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
[TBL] [Abstract][Full Text] [Related]
28. Yield of colonoscopy after recent CT-proven uncomplicated acute diverticulitis: a comparative cohort study.
Daniels L; Ünlü Ç; de Wijkerslooth TR; Stockmann HB; Kuipers EJ; Boermeester MA; Dekker E
Surg Endosc; 2015 Sep; 29(9):2605-13. PubMed ID: 25472747
[TBL] [Abstract][Full Text] [Related]
29. A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals.
Sekiguchi M; Kakugawa Y; Matsumoto M; Matsuda T
J Gastroenterol; 2018 Oct; 53(10):1109-1119. PubMed ID: 29359244
[TBL] [Abstract][Full Text] [Related]
30. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
[TBL] [Abstract][Full Text] [Related]
31. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
33. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.
Bretagne JF; Hamonic S; Piette C; Manfredi S; Leray E; Durand G; Riou F
Gastrointest Endosc; 2010 Feb; 71(2):335-41. PubMed ID: 19922930
[TBL] [Abstract][Full Text] [Related]
34. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
35. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China.
Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F
Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604
[TBL] [Abstract][Full Text] [Related]
36. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
38. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
[No Abstract] [Full Text] [Related]
39. Colonoscopy compliance and diagnostic yield in a large population-based colorectal cancer screening programme.
Zhao X; Wang S; Yuan Z; Yan S; Pang W; Liu X; Wang W; Yi B; Han Q; Zhang Q; Zhang X; Zhang C
Int J Colorectal Dis; 2023 Sep; 38(1):227. PubMed ID: 37700205
[TBL] [Abstract][Full Text] [Related]
40. Risk of metachronous neoplastic lesions during post-polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy.
Sekiguchi M; Kakugawa Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2230-2238. PubMed ID: 33626598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
